oncology

Showing 15 posts of 328 posts found.

START and Rome cancer institute partner to expand early-phase trial access in Italy

November 10, 2026
Diagnostics, Oncology, clinical trial collaboration, oncology

The START Center for Cancer Research is partnering with Rome-based Istituti Fisioterapici Ospitalieri (IFO) to establish an early-phase oncology clinical …

Highlighting the value of lab research for healthcare innovation

November 2, 2026
Cardiology, Devices, Neurology, Oncology, diagnostic tests, healthcare innovation, laboratory science, neurodegenerative disease, oncology

Diagnostic innovation and patient safety have dominated this yearโ€™s healthcare-focussed awards to mark European Laboratory Day. Staged by the European …

Charity commits ยฃ800,000 to AI research into late breast cancer recurrence

October 28, 2026
AI, Immunology, Oncology, breast cancer, cytology, oncology, research and development

Breast Cancer Now is investing ยฃ800,000 in two research projects using artificial intelligence to investigate why oestrogen receptor-positive (ER-positive) breast …

Most advanced breast cancer patients treated in community settings, Phesi study finds

October 26, 2026
Oncology, breast cancer, clinical trials, community healthcare, oncology

Most patients with advanced hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer are treated in community settings rather than academic centres, potentially …

BMSโ€™ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026
Research and Development BMS, Scottish Medicines Consortium, colorectal cancer, oncology

Bristol Myers Squibb (BMS) has announced that its Opdivo (nivolumab) has been accepted, in combination with Yervoy (ipilimumab), by the …

Astellas Pharmaโ€™s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026
Research and Development Astellas Pharma, Scottish Medicines Consortium, Vyloy, gastric cancer, oncology

Astellas Pharma, a pharmaceutical company creating medicines to address unmet medical needs, has announced that Vyloy (zolbetuximab), in combination with …

Rethinking oncology trial endpoints with generalised pairwise comparisons

November 4, 2025
Research and Development EMA, FDA, Oncology, One2Treat, clinical trials, generalised pairwise comparisons, net treatment benefit, oncology

For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival (OS) and progression-free survival (PFS) …

drug-trials

Pharma&โ€™s ovarian cancer therapy approved for use by NHS Scotland

October 29, 2025
Pharma&, Rubraca, Scottish Medicines Consortium, nhs scotland, oncology, ovarian cancer

Pharma& has announced that its treatment for ovarian cancer, Rubraca (rucaparib), has been accepted by the Scottish Medicines Consortium (SMC) …

Micrima announces upcoming launch of new UK breast cancer assessment

October 3, 2025
Research and Development Micrima, breast cancer, oncology

Breast cancer remains one of the leading health threats to women over 35 in the UK Micrima, a healthcare technology …

Combination treatments: Takedaโ€™s Implementation Framework and the broader landscape

September 23, 2025
Research and Development HIV/AIDS, Hepatology, NHS, NICE, Oncology, Takeda, combination therapy, oncology

Pharmafile talks to Emma Roffe, Oncology Country Head (UK & Ireland) about the combination treatment landscape and the impact of …

BioMed X and Servier launch Europeโ€™s first XSeed Labs to advance AI-powered antibody design

July 11, 2025
Research and Development BioLabs, BioMed X, Cancer, Oncology, Servier, XSeed Labs, antibody therapy, oncology

BioMed X and Servier have announced the launch of Europeโ€™s first XSeed Labs research project, located at the Spartners incubator …

Publishing image

ANGLEโ€™s Parsortix system used in new cancer biology research

June 10, 2025
Medical Communications, Research and Development Angle, Oncology, Parsortix system, R&D, biotech, oncology, scientific journals

ANGLE has announced three new peer-reviewed publications demonstrating the use of its Parsortix circulating tumour cell (CTC) harvesting system in …

BioNTech and Bristol Myers Squibb collaborate on bispecific antibody for solid tumours

June 6, 2025
Research and Development BioNTech, Oncology, bispecific antibody treatment, bristol myers squibb, oncology, partnership

BioNTech and Bristol Myers Squibb (BMS) have entered a partnership to collaboratively develop and commercialise BNT327, BioNTechโ€™s bispecific antibody, to …

Ryvu Therapeutics appoints Justyna ลปรณล‚tek to management board

May 29, 2025
Medical Communications, Research and Development Oncology, Ryvu Therapeutics, chief people officer, human resources, management board, oncology

Ryvu Therapeutics has promoted Justyna ลปรณล‚tek, chief people officer, to its management board. The appointment reflects the companyโ€™s focus on …

The Gateway to Local Adoption Series

Latest content